{"DataElement":{"publicId":"2220378","version":"1","preferredName":"Cetuximab Infusion Reaction Outcome Type","preferredDefinition":"the type of outcome for a cetuximab infusion reaction that occurred during this reporting period.","longName":"CETUX_INFRX_OUTCM_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2220375","version":"1","preferredName":"Cetuximab Infusion Reaction Outcome","preferredDefinition":"information relating to cetuximab infusion reaction outcome.","longName":"CETUX_INFUSRX_OUTCOM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2220353","version":"1","preferredName":"Cetuximab Infusion related reaction","preferredDefinition":"A monoclonal antibody specific for the epidermal growth factor receptor (EGFR), a tyrosine kinase that triggers cell division.  Cetuximab binds to and inhibits EGFRs, which are overexpressed on the cell surfaces of many types of tumors.  This agent blocks the tumor growth, invasion, and metastasis associated with the overexpression of cell-surface EGFRs. (NCI04):No value exists.","longName":"C1723:CL049508","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Cetuximab","conceptCode":"C1723","definition":"A recombinant, chimeric monoclonal antibody directed against the epidermal growth factor (EGFR) with antineoplastic activity. Cetuximab binds to the extracellular domain of the EGFR, thereby preventing the activation and subsequent dimerization of the receptor; the decrease in receptor activation and dimerization may result in an inhibition in signal transduction and anti-proliferative effects. This agent may inhibit EGFR-dependent primary tumor growth and metastasis. EGFR is overexpressed on the cell surfaces of various solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infusion related reaction","conceptCode":"CL049508","definition":"No value exists.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F42AB25E-7A85-1BC3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"ONEDATA","dateModified":"2005-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2220293","version":"1","preferredName":"Outcome","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"CL158230","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Outcome","conceptCode":"CL158230","definition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F428C665-7A6A-2F56-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"ONEDATA","dateModified":"2005-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008573","version":"1","preferredName":"Adverse Event Results","preferredDefinition":"the outcome or resolution of the patient's adverse events.","longName":"AE_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB869948-5E78-2537-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F428C665-7B7F-2F56-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2220377","version":"1","preferredName":"Cetuximab Infusion Reaction Outcome Type","preferredDefinition":"the type of outcome for a cetuximab infusion reaction that occurred during this reporting period.","longName":"CETUX_INFRX_OUTCM_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Resolved","valueDescription":"Resolved","ValueMeaning":{"publicId":"2574159","version":"1","preferredName":"Resolved","longName":"2574159v1.00","preferredDefinition":"One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recovered from Adverse Event","conceptCode":"C49498","definition":"One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEBC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F49FC15B-C48E-0791-E034-0003BA3F9857","beginDate":"2005-04-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-13","modifiedBy":"ONEDATA","dateModified":"2005-04-13","deletedIndicator":"No"},{"value":"Not resolved","valueDescription":"Not Resolved","ValueMeaning":{"publicId":"2567683","version":"1","preferredName":"Not Resolved","longName":"2567683","preferredDefinition":"Not Resolved","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D570-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"ONEDATA","dateModified":"2003-12-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F49FC15B-C490-0791-E034-0003BA3F9857","beginDate":"2005-04-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-13","modifiedBy":"ONEDATA","dateModified":"2005-04-13","deletedIndicator":"No"},{"value":"Resulted in death","valueDescription":"Resulted in death","ValueMeaning":{"publicId":"2574510","version":"1","preferredName":"Resulted in death","longName":"2574510","preferredDefinition":"Resulted in death","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F01B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"SHIDED","dateModified":"2005-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F49FC15B-C492-0791-E034-0003BA3F9857","beginDate":"2005-04-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-13","modifiedBy":"ONEDATA","dateModified":"2005-04-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008573","version":"1","preferredName":"Adverse Event Results","preferredDefinition":"the outcome or resolution of the patient's adverse events.","longName":"AE_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB869948-5E78-2537-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F49FB85A-5563-0700-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-13","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Outcome","type":"Preferred Question Text","description":"Outcome","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F49FBAFA-905F-73CF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-13","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}